Skip to content. | Skip to navigation

EXPERTISE
Everything that can be counted does not necessarily count, everything that counts cannot necessarily be counted.
Albert Einstein
 

Site map

An overview of the available content on this site. Keep the pointer still over an item for a few seconds to get its description.
  Cardiogenic Shock  
 

Ischemic Heart Disease

Deaths: 7.198.257

Years of life lost (YLL): 54.352.960

Years lost due to disability (YLD): 8.233.912

Disability-adjusted life years (DALYS): 62.586.874

(WHO)

 

It is estimated that 7-10% of patients who survive an acute myocardial infarction progress to cardiogenic shock, a physiologic state in which inadequate tissue perfusion results from cardiac insufficiency. These patients require immediate and rapid left ventricular support. In the absence of a mechanism to provide ventricular support, mortality rates range from 60-85%.

 

Inotropic medication, SVR modulation and volume management are typically used to stabilize the patient. Interventional intra-aortic balloon pump systems are frequently of value to reduce downstream load.

 

TheraGenesis clinically developed a novel catheter with an impeller-pump system designed to provide temporary left ventricular and circulatory support for patients with acute left heart failure.

 

amed_pic04150.jpg

  
     
 
spinner